期刊文献+

紫杉醇对p53缺失型肺癌细胞株H1299的生长抑制作用 被引量:2

Growth-inhibiting Effects of Paclitaxel on p53-deficient Strain of Human Lung Cancer H1299 Cells
下载PDF
导出
摘要 背景与目的:评价紫杉醇对p53缺失型肺癌细胞株H1299的生长抑制作用。材料与方法:分别以体外药物敏感试验(MTT法)、流式细胞术观察紫杉醇不同作用浓度、不同作用时间处理H1299细胞后,其生长抑制情况以及细胞周期、细胞凋亡等指标的变化,并以荧光显微镜观察细胞核形态的改变。结果:紫杉醇对H1299细胞毒性呈时间依赖性(P〈0.05);在紫杉醇1nmol/L以上各浓度组,随着紫杉醇浓度的增加,H1299细胞的存活率降低,与对照组间差异具有统计学意义(P〈0.05);各实验组H1299细胞的生长被阻滞于G2/M期,在0.1—1000nmol/L浓度范围内呈浓度依赖性(P〈0.05),其细胞凋亡比例在0.1—10nmol/L浓度范围内随浓度的增加而增高(P〈0.05);在时间依赖性试验中,10nmol/L作用时,G2/M期的阻滞于12h达高峰;1000nmol/L作用时于24h达高峰,延长1000nmol/L作用时间,H1299出现异常多倍体现象;凋亡发生呈时间依赖性,但高浓度诱导的凋亡较低浓度出现的时间晚。紫杉醇诱导的凋亡和G2/M期阻滞无相关性(P〉0.05)。荧光显微镜下可见细胞凋亡与细胞死亡共存现象。结论:紫杉醇可以同时诱导H1299细胞凋亡和死亡,对其生长抑制作用呈时间和浓度依赖性。 BACKGROUND AND AIM: To assess the growth-inhibiting effects of paclitaxel on p53-deficient human lung cancer H1299 cell line in vitro. MATERIALS AND METHOVS: H1299 cells were exposed to paclitaxel at different concentrations or different treatment times, then the growth-inhibiting effects were determined by MTT assay, the change of the cell cycle and apoptosis were analyzed with flow cytometry. Fluorescence microscopy was used to observe the nucleolus change stained by Hoechst33342 and PI. RESULTS: The growth inhibition effect of paclitaxel on H1299 cells was time-dependent(P〈0.05) With treatment concentration〉 1 nmol/L, the survival rate of H1299 cells in paclitaxel-treated groups decreased with increasing paclitaxel concentration, and showing significant difference with the survival rate in control group (P 〈0.05). The H1299 cells treated by 0.1- 1 000 nmol/L paclitaxel were blocked at G2/M phase, and the percentage of G2/M phase increased in concentration-dependent manner. The proportion of apoptosis increased as concentration changed from 0 to 10 nmol/L(P 〈0.05) The induction of apoptosis was time dependent(P〈0.05) and the percentage of G2/ M phase was highest at 12 h with paclitaxel at 10 nmol/ L. When treated with 1 000 nmol/ L paclitaxel, H1299 showed the highest G2/ M arrest at 24 h and some polyploidy cells appeared with prolonged treatment. Both concentrations could induce time-dependent apoptosis, but the higher concentration caused apoptosis later than the lower one. Apoptosis had no relationship with G2/M arrest(P 〉 0.05). The coexistence of cell apoptosis and necrosis could be observed in paclitaxel-treated H1299 calls under fluorescence microscopy. CONCLUSION: Paclitaxel could induce apoptosis and necrosis of H1299 at the same time. It inhibited the growth of H1299 cells in vitro in time-and concentration-dependent manners.
出处 《癌变.畸变.突变》 CAS CSCD 2008年第3期193-197,共5页 Carcinogenesis,Teratogenesis & Mutagenesis
关键词 肺癌 紫杉醇 细胞凋亡 细胞周期 lung neoplasms paclitaxel apoptosis cell cycle
  • 相关文献

参考文献6

  • 1朱京童,白玉,司文秀,刘洪喜,任曲辉.中药白头翁提取物抗肿瘤活性的体外实验研究[J].癌变.畸变.突变,2007,19(1):67-69. 被引量:13
  • 2Wang TH, Wang HS,Soong YK. Paclitaxel-induced cell death: where the cell cycle and apoptosis come together [J] . Cancer. 2000, 88(11) : 2619 - 2628.
  • 3Jordan MA, Toso R J, Thrower D, et al. Mechanism of mitotic blockand inhibition of cell proliferation by taxol at low concentrations[J] . Proc Natl Acad Sci USA, 1993, 90(10): 9552 - 9556.
  • 4long BH, Fairchild CR. Paclitaxel inhibits progression of mitotic cells to G1 phase by interference with spindle formation without affecting other microtubule functions during anaphase and telephase [J]. Cancer Res, 1994,54(16) :4355 - 4361.
  • 5Lin HL, Chang YF, Liu TY, et al. Submicromolar paclitaxel induces apoptosis in human gastric cancer cells at early G1 phase [J]. Aticancer Res, 1998, 18(5A) :3443- 3450.
  • 6Roberts JR, Allison DC, Donehower RC, et al. Development of polyploidyzation in taxol- resistant human leukaemia cells in vitro [J]. Cancer Res, 1990,50(3) :710- 716.

二级参考文献2

  • 1司徒镇强 吴军正.细胞培养[M].西安:世界图书出版社,2003.66-67.
  • 2国家中医药管理局《中华本草》编委会 1603.中华本草(上册)[M].上海科学技术出版社,1998.404.

共引文献12

同被引文献20

  • 1王宏羽,张湘茹,屈风莲,储大同,孙燕.复发或难治性非小细胞肺癌的化疗进展[J].癌症进展,2005,3(3):237-242. 被引量:3
  • 2Kawasaki M,Nakanish Y,Kuwano K,et al.The utility of p53 immunostaining of transbronchial biopsy specimens of lung cancer:p53 overexpression predicts poor prognosis and chemoresistance in advanced non-small cell lung cancer[J].Clin Cancer Res,1997,3(7):1195-1200.
  • 3Brambilla E,Cazdar A.Pathogenesis of lung cancer signalling pathways:roadmap for therapies[J].Eur Respir J,2009,33 (6):1485-1497.
  • 4Woodcock DM,Berg S,Kang YK,et al.PhaseⅠ/Ⅱstudy of taxol 96-hour infusion refractory lymphoma and breast cancer:Pharmacodynamic and analysis of multidrug resistance[J].Proc Amer Soc Clin Oncol,1993,12:134.
  • 5Dorsey JF,Mintz A,Tian X,et al.Tumor necrosis factor-related apoptosis-inducing ligand(TRAIL) and paclitaxel have cooperative in vivo effects against glioblastoma multiforme cells[J].Mol Cancer Ther,2009,8(12):3285-95.
  • 6Lakin ND,Jackson SP.Regulation of p53 in response to DNA damage[J].Oncogene,1999,18(53):7644-7655.
  • 7Bergstralh DT,Ting JP.Microtubule stabilizing agents:their molecular signaling consequences and the potential for enhancement by drug combination[J].Cancer Treat Rev, 2006,32(3):166-179.
  • 8Yagi Y,Fushida S,Harada S,et al.Effects of valproic acid on the cell cycle and apoptosis through acetylation of histone and tubulin in a scirrhous gastric cancer cell line[J].J Exp Clin Cancer Res,2010,29(1):149.
  • 9Guntur VP,Waldrep JC,Guo JJ,et al.Increasing p53 protein sensitizes non-small cell lung cancer to paclitaxel and cisplatin in vitro[J].Anticancer Res,2010,30(9):3557-3564.
  • 10Liu WL,Green N,Seymour LW,et al.Paclitaxel combined with siRNA targeting HPV 16 oncogenes improves cytotoxicity for cervical carcinoma[J].Cancer Gene Ther,2009,16(10): 764-775.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部